12
feature
Psychedelics: New Frontiers in Alternative Medicine
|
cannabissciencetech.com
A New Clinical Trial
in South Africa Aims
to Study the Effect of Psilocybin on HIV Positive
Women with Major Depressive Disorder
B Y E R I N M C E V O Y
With an increased interest in the medical uses of psychedelics, new studies are emerging
to explore their potential to treat mental health illnesses. One company, Cannsun
Medicinal Global, is looking to address physical and mental health diseases affecting a
large population in South Africa by studying the effects of psilocybin with psychotherapy
on HIV positive women who have major depressive disorder (MDD). Cannsun is a
biopharmaceutical company that develops and commercializes new medicines, with a
focus on research and development in both women's health and mental health. In this
interview, Donaghue Woodman, Head of Research and Development and Chief Medical
Information Officer at Cannsun, provides an in-depth look at their current clinical trial on
the effects of psilocybin in treating a prevalent yet unresolved issue in South Africa (1).
Image
credit:
contentdealer/
adobe.stock.com
